Role of blue-light cystoscopy in the management of non-muscle invasive bladder cancer

被引:0
|
作者
Pignot, G. [1 ]
机构
[1] Univ Paris Sud, Hop Bicetre, Serv Urol, F-94270 Le Kremlin Bicetre, France
来源
PROGRES EN UROLOGIE | 2015年 / 25卷 / 10期
关键词
Non-muscle invasive bladder cancer; Cystoscopy; Diagnosis; Recurrence; Cost-effectiveness; Indications; GUIDED FLUORESCENCE CYSTOSCOPY; CARCINOMA IN-SITU; PHOTODYNAMIC DIAGNOSIS; COST-EFFECTIVENESS; FOLLOW-UP; COST/BENEFIT/THERAPEUTIC VALUE; TRANSURETHRAL RESECTION; FLEXIBLE CYSTOSCOPY; MUSCLE; RECURRENCE;
D O I
10.1016/j.purol.2015.05.003
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Blue-light cystoscopy aims to facilitate the detection of bladder tumors in order to optimize the completeness of resection. We performed a literature analysis using data from Medline and according to PRISMA guidelines. Several meta-analyses have confirmed the interest of the blue-light cystoscopy in terms of improved detection rate and disease-free survival compared to standard white-light cystoscopy. These benefits outweigh the initial costs related to the acquisition of specific equipment, allowing an improvement in quality-adjusted life-years and a reduction of costs over time. Indications vary according to guidelines and must take into account equipment and logistic constraints on each center. The objective of this article is to make a focus on the role and the interest of blue-light cystoscopy in the management of NMIBC in 2015. (C) 2015 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:607 / 615
页数:9
相关论文
共 50 条
  • [31] NBI CYSTOSCOPY IN NON-MUSCLE INVASIVE BLADDER CANCER - A PROSPECTIVE COMPARISON TO THE STANDARD APPROACH
    Geavlete, Bogdan
    Jecu, Marian
    Mirciulescu, Victor
    Moldoveanu, Cristian
    Stanescu, Florin
    Multescu, Razvan
    Georgescu, Dragos
    Geavlete, Petrisor
    JOURNAL OF ENDOUROLOGY, 2012, 26 : A471 - A471
  • [32] Blue versus white light for transurethral resection of non-muscle invasive bladder cancer (Review)
    Bellut, L.
    Kunath, F.
    UROLOGE, 2022, 61 (04): : 411 - 414
  • [33] Alternatives for cytology in the management of non-muscle invasive bladder cancer
    Amiel G.E.
    Shu T.
    Lerner S.P.
    Current Treatment Options in Oncology, 2004, 5 (5) : 377 - 389
  • [34] Novel approaches to the management of non-muscle invasive bladder cancer
    Kamat, Ashish M.
    CLINICAL CANCER RESEARCH, 2024, 30 (10)
  • [35] CUA guidelines on the management of non-muscle invasive bladder cancer
    Kassouf, Wassim
    Traboulsi, Samer L.
    Kulkarni, Girish S.
    Breau, Rodney H.
    Zlotta, Alexandre
    Fairey, Andrew
    So, Alan
    Lacombe, Louis
    Rendon, Ricardo
    Aprikian, Armen G.
    Siemens, D. Robert
    Izawa, Jonathan I.
    Black, Peter
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2015, 9 (9-10): : E690 - E704
  • [36] Current Concepts in the Management of Non-Muscle Invasive Bladder Cancer
    Mandhani A.
    Indian Journal of Surgical Oncology, 2017, 8 (3) : 397 - 402
  • [37] MANAGEMENT OF VARIANT HISTOLOGY IN NON-MUSCLE INVASIVE BLADDER CANCER
    Prado, Kris
    Greenberg, Daniel
    Zhang, Chiyuan
    Sun, Andrew
    Skinner, Eila
    JOURNAL OF UROLOGY, 2020, 203 : E263 - E263
  • [38] The role of hyperthermia as a treatment for non-muscle invasive bladder cancer
    Bahouth, Zaher
    Halachmi, Sarel
    Moskovitz, Boaz
    Nativ, Ofer
    EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (02) : 189 - 198
  • [39] The role of pelvic lymphadenectomy in non-muscle invasive bladder cancer
    Lin, James
    Deibert, Christopher M.
    Holder, Dara
    Benson, Mitchell C.
    McKiernan, James M.
    CANADIAN JOURNAL OF UROLOGY, 2014, 21 (01) : 7108 - 7113
  • [40] Narrow band imaging versus white light cystoscopy alone for transurethral resection of non-muscle invasive bladder cancer
    Lai, Lillian Y.
    Tafuri, Sean M.
    Ginier, Emily C.
    Herrel, Lindsey A.
    Dahm, Philipp
    Maisch, Philipp
    Lane, Giulia Ippolito
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2022, (04):